This study was designed to 1) describe the demographics and 2) determine the efficacy of a head and neck cancer screening program to optimize future programs. STUDY DESIGN: Database analysis plus chart review. SETTING: Tertiary care academic medical center. SUBJECTS AND METHODS: After Institutional Review Board approval, we reviewed our 14-year experience (1996-2009) conducting a free annual head and neck cancer screening clinic. Available demographic and clinical data, as well as clinical outcomes, were analyzed for all participants (n ϭ 761). The primary outcome was the presence of a finding suspicious for head and neck cancer on screening evaluation. RESULTS: Five percent of participants had findings suspicious for head and neck cancer on screening evaluation, and malignant or premalignant lesions were confirmed in one percent of participants. Lack of insurance (P ϭ 0.05), tobacco use (P Ͻ 0.001), male gender (P ϭ 0.03), separated marital status (P ϭ 0.03), and younger age (P ϭ 0.04) were the significant demographic predictors of a lesion suspicious for malignancy. Patients complaining of a neck mass (P Ͻ 0.001) or oral pain (P Ͻ 0.001) were significantly more likely to have findings suspicious of malignancy. A high percentage (40%) was diagnosed with benign otolaryngologic pathologies on screening evaluation. CONCLUSION: A minority of patients presenting to a head and neck cancer screening clinic will have a suspicious lesion identified. Given these findings, to achieve maximal potential benefit, future head and neck cancer screening clinics should target patients with identifiable risk factors and take full advantage of opportunities for education and prevention.
H ead and neck cancer encompasses a range of malignancies with a relatively stable incidence. Approximately 30,000 such cancers are diagnosed annually in the United States, with roughly 10,000 deaths each year. 1 Morbidity and mortality from head and neck cancer are closely linked to stage; patients diagnosed with tumors restricted to the primary site have an average five-year survival of 80 percent compared with only 40 percent when patients present with metastases. 2 The majority of head and neck cancers are diagnosed at an advanced stage. 3 Despite advancements in diagnostics and treatment, prognosis remains poor, with lower survival when compared with other neoplasms. 4 The fundamental goal of screening programs is the identification of individuals at risk for a disease for which early detection is possible. In the 1960s, Wilson and Jungner described oft-cited characteristics of diseases that merit screening, including the significance of the health problem, the presence of a detectable early stage at which point interventions are more efficacious, and the availability of a facile and cost-effective screening test. 5 Given significant morbidity and mortality, the survival advantage of early detection, the ability to diagnose early stage tumors with a clinical examination, and that patients with certain risk factors have a substantially higher incidence, head and neck cancer appears ideally suited for screening programs. 6 The existing data are not conclusive concerning the efficacy and utility of routine screening for head and neck cancer. 7, 8 The major limiting factor is the absence of welldesigned, randomized prospective trials, which has led the US Preventive Services Task Force not to recommend routine screenings. 9 The only randomized controlled trial, involving greater than 100,000 patients, suggested that visual screening for oral cancers is only efficacious in high-risk populations, namely tobacco and alcohol abusers. 10 Otolaryngologists are uniquely equipped to conduct head and neck cancer screening because of considerable experience with upper airway anatomy and pathology, since a detailed physical examination is the preferred modality to detect neoplasms at early stages. 6 The University of Michigan has conducted a free annual screening clinic for head and neck cancer for the past 14 years. This study is designed to review our experience and to guide the implementation of future such clinics.
Materials and Methods

Screening Clinics and Subjects
The University of Michigan Department of Otolaryngology has conducted a free annual community head and neck cancer screening program in conjunction with our Comprehensive Cancer Center. Patients were recruited in a variety of ways, including advertisements in print media, on the radio, and in public transportation vehicles; flyers placed in low-income health clinics; and via the Internet. Participants were encouraged to make an appointment in advance via an advertised telephone number, although walk-ins were also accepted as space allowed. They were allowed to "self-select" to attend the clinic because there was no attempt made at the time of initial inquiry to screen for higher risk individuals. Those presenting for evaluation filled out a questionnaire, designed for the screening clinic, with demographic data and information about risk factors and presenting symptoms.
The medical encounter involved a medical history and physical examination (including flexible pharyngoscopy and laryngoscopy where appropriate) with a physician or physician assistant. All patients with concerning findings were referred for further care as appropriate, and schedulers were present on site to secure future appointments. Patients who preferred not to arrange follow-up appointments at our institution were encouraged to seek care elsewhere and were given information about other local otolaryngologists. Financial counseling was made available to all patients who required assistance. Patients with findings or symptoms requiring follow-up by a primary care provider or other specialty provider were referred appropriately. Clinical information regarding findings, concerns, and recommendations were provided to participants to be shared with their health care providers. Smoking cessation counseling and education about cancer risk factors (including individual discussions, group sessions, and handouts) were also integral parts of the program.
Data Acquisition
The research protocol was approved by the Institutional Review Board of the University of Michigan Medical School. All of the prospectively collected demographic information, presenting symptoms, clinical findings, and recommendations were extracted from the questionnaires. Outcomes, including follow-up data and the results of workup for malignancy, were obtained through chart abstraction.
Data Analysis
SAS version 9.2 (SAS Institute, Cary, NC) was used to obtain descriptive statistics and to fit models to the data. Frequency distributions for all variables were calculated. The logistic regression model was run to estimate the odds ratios of finding a lesion suspicious for cancer given each of the variables. A logistic model was also fit to determine the probability of returning for a follow-up appointment when this was recommended. Logistic regression was used to determine odds ratios and P values for each pair of symptoms.
Results
Demographics
Of 761 eligible subjects, two did not have analyzable data and were excluded. Among the included subjects, 58 percent were male, and ages ranged from 17 to 100 years with a mean of 58 years (Table 1 ). Most subjects (76%) were white, 57 percent were married, 86 percent had a primary care provider (PCP), and 68 percent reported having medical insurance. Sixty-six percent were current or former tobacco users, and 37 percent of patients reported drinking alcohol regularly. The majority of patients (55%) learned of the screening clinic through newspaper advertisements. Further demographic information is summarized in Table 2 .
Symptoms and Outcome
The vast majority (87%) of patients reported at least one symptom. The most common complaint reported was hoarseness (60%), followed by dysphagia (42%). Symptom frequencies are summarized in Table 3 .
Slightly more than half (53%) of patients had normal screening examinations, and the remaining 47 percent had abnormal findings (Fig 1) . Abnormal findings that were presumably benign were identified in 42 percent of all participants. Laryngopharyngeal reflux was the most common diagnosis, identified in 54 percent of patients in whom pathology was recognized. All of the abnormal findings and their frequencies are summarized in Table 4 .
There were 41 patients (5%) who had findings suspicious for cancer. Of these, seven patients (0.9%) had malignant or premalignant lesions confirmed. These included four cases of mucosal squamous cell carcinoma, two cases of dysplastic leukoplakia, and one case of papillary thyroid cancer; three of the five invasive cancers were diagnosed at early stages ( Table 5 ). Another 12 of these individuals underwent workup and were diagnosed with benign conditions. The remaining 25 patients did not return to our institution for follow-up. 
Predictors of Primary Outcome
Lack of insurance (P ϭ 0.05) was a significant predictor of a lesion suspicious for malignancy. Participants who currently chew tobacco had significantly higher rates of suspicious findings compared with those who never used tobacco (P Ͻ 0.001). Neither users of inhaled tobacco (current and former) nor "ever" tobacco users had sig-nificantly different outcomes compared with those without a tobacco abuse history. Regular alcohol use was not significantly associated with the primary outcome. Male gender (P ϭ 0.03) and separated marital status (P ϭ 0.002 vs married) both correlated with a significantly higher incidence of a suspicious finding. The odds ratios and significance of each demographic variable and symp- tom in predicting a finding suspicious for cancer are presented in Tables 2 and 3 . On univariate analysis, the patient-reported symptoms that were significantly associated with a finding suspicious for cancer were oral pain (P Ͻ 0.001) and neck mass (P Ͻ 0.001). Examining the symptom distribution by age, the odds of oral pain and neck mass both decreased significantly as age increased. Age was also a significant covariate (P ϭ 0.04), with the likelihood of a suspicious finding decreasing as age increased; the average age of patients with a suspicious lesion was 54 years, compared with an average of 59 years among the remainder of the population (Table 1) . 
Follow-up
A total of 94 subjects were encouraged to return to the outpatient otolaryngology clinic and given the option to make follow-up appointments at the time of the screening clinic. This included 41 patients with suspicious lesions and 53 with suspected benign otolaryngologic conditions. Of these, 39 (41%) returned for appointments. Nineteen of 41 patients (46%) with findings suspicious for cancer made and kept appointments at our institution. Twenty of 53 patients (38%) with suspected benign conditions returned to the clinic for follow-up. Data were not available concerning patients who chose to seek care at other institutions. On univariate analysis, using gender, education, referral pattern, presence of a PCP, and insurance status as variables, there were no significant predictors of whether or not these patients returned for evaluation, although there was a trend towards better follow-up in patients with insurance (odds ratio, 12.3; P ϭ 0.09).
Discussion
Primary Outcome
The incidence of suspicious lesions and confirmed neoplasms in our study was low. A review of nine studies on oral cancer screening programs involving a combined total of more than 13 million patients reported a range from 0.2 to 9.5 percent of patients with suspicious lesions, with confirmed malignancies between 0 and 2.4 percent. 11 Smaller studies evaluating utility of screening for laryngeal cancer have demonstrated similar results. 12, 13 Programs utilizing screening of high-risk individuals by primary care providers have proven feasible, but the number of diagnosed malignancies remained low. 14 One reason for these results is the fact that high-risk populations might not constitute the majority of the patients who undergo screening. Individuals were allowed to "self select" after hearing or reading advertisements that defined risk factors and suspicious symptoms; no attempts were made to triage high-risk individuals. Another explanation for these results is the low incidence of head and neck cancer compared with other diseases for which screening programs have proven efficacious. 15 As a result, modalities other than the conventional physical exam, such as brush biopsy, fluorescence imaging, and toluidine blue staining have been explored but have not proven efficacious. 16 The dearth of convincing data has led advisory groups to conclude that there is insufficient evidence to recommend routine screening for oral cancers. 11, 15 One encouraging finding in our study was the fact that most of the neoplasms identified were either pre-cancers or early stage tumors, implying that screening was effective in discovering tumors when they were more curable, consistent with prior conclusions. 17 Whereas larger studies have not confirmed these findings on a broader scale, differing types of clinical screening programs and variable research design make comparisons difficult.
Demographics
Patients who did not have medical insurance were more likely to have suspicious lesions. This confirms data demonstrating a higher risk of head and neck neoplasms among patients with limited socioeconomic resources and medical access. 18, 19 Prior screening programs that focused on disadvantaged populations noted that many exhibited high-risk behaviors, with significant socioeconomic and cultural barriers to screening. 20 The low percentage of uninsured patients in our population echoes similar findings elsewhere. 21 The majority of our patients was white, despite the fact that minorities are disproportionately affected by head and neck cancer with worse outcomes. 1 In general, one of the goals of free screening clinics is to provide service to populations that do not otherwise have access to medical care. Given this objective, compounded by a significantly higher rate of suspicious lesions in this population, future clinics should attempt to recruit patients who do not have access to medical services through more traditional means. Specific means to accomplish this goal include direct recruitment at low-income health clinics and shelters, as well as preclinical triage favoring higher risk individuals.
The association between tobacco and alcohol abuse and head and neck cancers has been established, and epidemiologic studies have demonstrated causation. 22 Based on the only randomized controlled trial to address this issue, head and neck cancer screening should target those with estab- lished risk factors. 10 One potential explanation for our findings is a disproportionate percentage of smokers attending screening clinics, comparable with results of a similar study. 23 The emergence of human papilloma virus-related tumors may also be altering the demographics and risk factor profile of head and neck cancers, although we did not specifically test for human papilloma virus. 24 Younger age was a predictor of a concerning finding in our study; however, the average age in this group was similar to the rest of the study population. The statistical significance of this finding does not clearly translate into clinical significance, given the concordance with published literature, the small absolute age difference, and the fact that the majority of head and neck malignancies are diagnosed in the fifth through seventh decades. 1 Our study also corroborates the male predominance with regard to head and neck cancers. 25 
Clinical Factors
The high number of patients who presented with head and neck symptoms may explain the fact that some traditional risk factors were not significant predictors in our population, given the bias based on self-referral patterns. One study analyzing a screening clinic similar in structure to ours also reported a majority of patients who presented with symptoms, although they did not correlate with abnormal findings. 21 To our knowledge, ours is the first report to specify the presenting symptoms and benign conditions diagnosed in this type of clinic, both of which were considerably more common than expected.
Oral pain was the most significant predictor of patients with suspicious lesions. Oral pain is an established harbinger of head and neck cancer and is one of the more common presenting symptoms; the absence of conspicuous symptoms prior to the onset of pain may explain the advanced state of most lesions at the time of diagnosis. 26 Patients complaining of a neck mass were more likely to have suspicious lesions. Whereas this contradicts our finding that the confirmed neoplasms were mostly diagnosed at early stages, a number of neck masses were initially concerning for malignancy but were related to benign causes. As a general rule, all patients presenting with a neck mass, particularly in the presence of significant risk factors for cancer, merit further workup.
Patients complaining of hoarseness did not have significantly higher rates of suspicious lesions despite the established association between persistent hoarseness and head and neck cancer. 27 Patient perceptions of vocal pathology are subjective and do not always correlate with medically diagnosed vocal disorders. Moreover, benign pathologies that were common in our study population frequently contribute to a range of vocal problems. 28 Symptoms that are concerning for head and neck cancer are nonspecific and have considerable overlap with those that are caused by benign diseases.
Follow-up
One unexpected finding of this study was the poor follow-up in patients for whom further evaluation was deemed necessary. Less than half of all of these patients returned to our center for care. Given that patients knew where to present and that appointments were scheduled on the day of screening, logistical issues were unlikely contributory. Whereas the mechanism for follow-up was clearly defined and facilitated, responsibility for returning was left to the patients. Prior oral cancer screening clinics in urban underserved areas have also demonstrated poor follow-up rates among patients with concerning findings. 29 In our study, the social variables that were measured (presence of a PCP or medical insurance) did not influence patients' ability to return. The trend towards better follow-up among those with insurance would be expected. Future clinics should attempt to explore barriers to follow-up with patients to ensure that they are appropriately managed, especially when a finding suspicious for malignancy is encountered. We intend to more actively monitor and pursue follow-up of patients with such findings.
Other Advantages of Screening Clinics
Outcomes involving education, prevention, community engagement, and facilitated access to health care are less easily measured. Prior head and neck cancer screening clinic participants had considerable gaps in knowledge about the disease, and a large proportion had significant risk factors. 24 Head and neck cancer screening programs have proven successful at increasing awareness of the disease, as well as risk factors and warning signs. 21, 27 The psychologic benefit of reassuring a patient that he/ she does not have cancer is also worthwhile because a sizable percentage of patients presenting for otolaryngologic evaluation have a significant fear of malignancy. 30 The fact that many participants had abnormal findings also indicates the usefulness of the program; the diagnosis, treatment, and education for a litany of benign head and neckrelated conditions in hundreds of patients is inherently valuable. The effort necessary for intensive education and risk factor modification are considerable; having resources in place on a day dedicated to this task both relieves opportunity cost and facilitates logistics.
Evidence-Based Changes
Based on the findings in this study, advertising for our 2010 screening clinic was broadened to include more than 60 regional free medical clinics and shelters. Triaging gave priority to patients without insurance and/or with suspicious complaints. The incidence of suspicious lesions in this year's clinic was more than double the incidence reported in this study. We do not know whether this trend will persist, nor do we have statistical analysis of these early data. No data about follow-up rates are yet available. We anticipate a future report detailing the results from future clinics employing the evidence-based modifications developed through the current study.
Strengths and Weaknesses
To our knowledge, this is the largest study evaluating a head and neck cancer screening clinic of this kind. While retrospective in nature, patient recruitment and all data concerning the screening clinic encounter were amassed prospectively, limiting recall bias. As a single-institution series, the data may or may not be directly relevant to other such programs. A major shortcoming of this study is the poor follow-up among patients with a suspicious lesion, which precluded the ability to confirm or exclude neoplasms in that cohort. However, using the presence of a "suspicious lesion" as the primary outcome was deemed appropriate, given that the general goal of screening programs is to identify patients who require further workup.
Conclusion
A small percentage of patients presenting to a head and neck cancer screening clinic will have a suspicious lesion identified on examination. The demographic factors, signs, and symptoms associated with a higher risk of such a lesion include lack of health insurance, oral pain, or neck mass. Screening clinics additionally provide an excellent opportunity to disseminate information about head and neck cancer and to introduce interventions designed to modify risk factors. Patients with concerning findings on screening may not readily present for further evaluation, and efforts to improve follow-up in this cohort are necessary. Given these findings, future head and neck cancer screening clinics should target patients with identified risk factors who are most in need of these services and should take advantage of opportunities for education and prevention.
